# Ectoenzyme_Tcells
Analysis materials associated with the publication: 
Mitra A, Thompson B, Strange A, Amato CM, Vassallo M, Dolgalev I, Hester-McCullough J, Muramatsu T, Kimono D, Puranik AS, Weber JS, Woods D. A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance. Clin Cancer Res. 2023 Jul 28:CCR-23-0653. doi: 10.1158/1078-0432.CCR-23-0653. Epub ahead of print. PMID: 37505479.

Bulk RNA-Seq: GSE224099

Public scRNA-Seq datasets:

GSE11597823 
Jerby-Arnon, L. et al. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Cell 175, 984-997 e924 (2018). https://doi.org:10.1016/j.cell.2018.09.006

GSE17999424
Liu, B. et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer 3, 108-121 (2022). https://doi.org:10.1038/s43018-021-00292-8

GSE14965225
Oh, D. Y. et al. Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell 181, 1612-1625 e1613 (2020). https://doi.org:10.1016/j.cell.2020.05.017

GSE12057526 
Sade-Feldman, M. et al. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma. Cell 175, 998-1013 e1020 (2018). https://doi.org:10.1016/j.cell.2018.10.038
